Armada Health Care Supports Academy of Managed Care Pharmacy Biosimilars Project

Armada Health Care Supports Academy of Managed Care Pharmacy Biosimilars Project

ID: 308111

(firmenpresse) - FLORHAM PARK, NJ -- (Marketwired) -- 10/22/13 -- Armada Health Care (Armada), the nation's largest specialty pharmacy group purchasing and channel management organization, is pleased to announce that it is supporting the Academy of Managed Care Pharmacy (AMCP) and its efforts on biosimilars within the specialty pharmacy channel.

"We are excited to have established a collaborative relationship with AMCP specifically with its initiatives on biosimilars," said Armada's CEO, Larry Irene. "As an industry leader, Armada is honored to have been chosen to help with this relevant topic in specialty pharmacy."

The title of the biosimilars project is: "." This project will bring together key stakeholders to explore how to accelerate the adoption of coordinated data approaches to more rapidly demonstrate the safety and efficacy of biosimilars.

The purpose of this initial forum is to determine the feasibility of launching a collective intelligence system, which will serve to document the safety and efficacy of biosimilars. This newly created system will fill a data void in the market and offer a new set of information points to the industry as reference. It will include detailed information for any innovator specialty drug; identify barriers to implementation of such a system prior to the market launch of the first biosimilar; develop a high level action plan for managed care pharmacies while also developing a data consortium to launch a biosimilars collective intelligence system.

Through the support provided by Armada and others, AMCP will publish a Partnership Forum report in the Academy's Journal of Managed Care Pharmacy (JMCP). Follow-up informational and educational initiatives will also be developed and offered through AMCP.

Armada Health Care (Armada) is the industry's largest specialty pharmacy channel management organization. Armada provides comprehensive and cost effective access to the nation's $100 billion plus specialty pharmacy industry. Armada offers pharmacy providers, manufacturers, health plans and wholesale distributors a total channel management solution through customized patient programs, prescription-data-management services, online patient management platforms and unique group purchasing agreements on specialty pharmacy products. For more information about Armada, please visit .







Darcey Brennan
Vice President of Marketing
Armada Health Care
100 Campus Drive
Florham Park, NJ 07932
973-564-8004


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  FirstHealth of the Carolinas Selects M*Modal for Enterprise-Wide Clinical Documentation Solutions IntelliCell BioSciences Receives Notice of Its Thailand Patent Application for Its Stem Cell Extraction Technology
Bereitgestellt von Benutzer: Marketwired
Datum: 22.10.2013 - 13:35 Uhr
Sprache: Deutsch
News-ID 308111
Anzahl Zeichen: 0

contact information:
Town:

FLORHAM PARK, NJ



Kategorie:

Healthcare



Diese Pressemitteilung wurde bisher 255 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Armada Health Care Supports Academy of Managed Care Pharmacy Biosimilars Project"
steht unter der journalistisch-redaktionellen Verantwortung von

Armada Healthcare (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Armada Healthcare



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z